"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A1,US 2009/0312646 A1,035-512-311-630-245,2009-12-17,2009,US 33447808 A,2008-12-14,US 33447808 A;;US 20878308 A;;US 97213607 P,2007-09-13,"OPTICAL DETECTION OF SEIZURE, A PRE-SEIZURE STATE, AND CEREBRAL EDEMA AND OPTICAL FIBER DETECTION OF THE SAME","A method for using optical parameters to monitor for a physiological event and/or a state prior to the physiological event includes the steps of: illuminating neural tissue with diagnostic light of a predetermined frequency at a predetermined location; detecting magnitude of optical scattering by neural tissue of the diagnostic light as a function of time; and determining a signature signal of the optical scattering of the diagnostic light before the physiological event in the neural tissue becomes clinically manifested. An apparatus includes a source of diagnostic light of a predetermined frequency for illuminating neural tissue at a predetermined location, a detector of optical scattering and/or optical absorption by neural tissue of the diagnostic light as a function of time, and a signal processor for determining a signature signal of the optical scattering and/or optical absorption of the diagnostic light before the physiological event becomes clinically manifested.",UNIV CALIFORNIA,BINDER DEVIN;;OWEN CHRISTOPHER;;MATHEWS MARLON,,https://lens.org/035-512-311-630-245,Patent Application,yes,5,11,1,1,0,A61B5/0059;;A61B5/0086;;A61B5/4094;;A61B5/4878;;A61B5/6814;;A61B5/6848;;A61B5/0042;;A61B5/0059;;A61B5/6814;;A61B5/6848;;A61B5/4878;;A61B5/0086;;A61B5/4094;;A61B5/0042,A61B6/00,600/478,0,0,,,,DISCONTINUED
2,US,A1,US 2014/0296693 A1,074-771-247-983-345,2014-10-02,2014,US 201313855491 A,2013-04-02,US 201313855491 A,2013-04-02,"PRODUCTS OF MANUFACTURE AND METHODS USING OPTICAL COHERENCE TOMOGRAPHY TO DETECT SEIZURES, PRE-SEIZURE STATES AND CEREBRAL EDEMAS","In alternative embodiments, the invention provides compositions, products of manufacture and medical devices, and methods, using optical coherence tomography to monitor for a physiological event and/or a state prior to the physiological event. The invention also provides computer program products and computer implemented methods to capture, analyze, and display optical coherence tomography images of neural tissue to measure, detect and/or monitor for a physiological event and/or a state prior to the physiological event.",UNIV CALIFORNIA,BINDER DEVIN K;;PARK HYLE;;HSU MIKE S,THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (2013-04-02),https://lens.org/074-771-247-983-345,Patent Application,yes,6,4,1,1,0,A61B5/0066;;A61B2562/12;;A61B5/0042;;A61B5/4094;;A61B5/4094;;A61B2562/12;;A61B5/0066;;A61B5/0042,A61B5/00,600/408;;600/425;;600/427,6,3,069-781-124-427-857;;162-406-073-814-81X;;041-991-723-723-251,10.1364/boe.3.002700;;23162709;;pmc3493229;;10.3171/2010.2.jns091017;;20205509;;23246145;;pmc3595359;;10.1016/j.yebeh.2012.10.027,"Reynolds et al., ""Imaging Cerebral Edema Using Optical Coherence Tomography"", 12th Annual UC System Wide Bioengineering Symposium, June 13-15, 2011;;Program for 12th Annual UC System Wide Bioengineering Symposium;;""OCT News 2013 Student Paper Awarded to Carissa Reynolds from University of California Riverside"", Jan 17 2013;;Eberle et al., ""In vivo detection of cortical optical changes associated with seizure activity with optical coherence tomography"", Biomedical Optics Express, 10/2/2012;;Gill et al., ""Early detection of cerebral edema in vivo"", J Neurosurg 114, Feb 2011;;Binder et al., ""Toward new paradigms of seizure detection"", Epilepsy Behav. March 2013",DISCONTINUED
3,US,B2,US 10420918 B2,127-916-254-172-394,2019-09-24,2019,US 201414539385 A,2014-11-12,US 201414539385 A;;US 201213666773 A;;US 201161555351 P,2011-11-03,Compositions and methods for reducing traumatic edema of the central nervous system,"The invention provides compositions and methods for the treatment and/or reversal of an edema, e.g., including a central nervous system (CNS) edema, e.g., a brain or a spinal edema, edema in a burned or an injured tissue such as skin, or any tissue edema. In alternative embodiments, the invention provides compositions and methods for a direct treatment and reversal of an edema, e.g., CNS, brain or spinal edema, including a membrane transport device, in vitro and in vivo characterization of edema, and the sensitive early optical detection of the edema, e.g., tissue, CNS or cerebral edema.",UNIV CALIFORNIA,RODGERS VICTOR G J;;BINDER DEVIN;;MCBRIDE DEVIN;;HSU MICHAEL;;PARK B HYLE,THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (2017-04-03),https://lens.org/127-916-254-172-394,Granted Patent,yes,4,1,3,3,0,A61K38/38;;A61K38/40;;A61B5/4878;;A61B5/6868;;A61B5/0066;;A61P43/00;;A61B5/0066;;A61B5/4878;;A61B5/6868;;A61K38/38;;A61K38/40;;A61L29/043;;A61L29/044;;A61L29/16;;A61M27/002;;A61M2027/004,A61M27/00;;A61B5/00;;A61K38/38;;A61K38/40;;A61L29/04;;A61L29/16,,5,5,015-021-478-550-640;;014-055-914-340-682;;124-642-463-118-904;;084-923-550-771-583;;015-037-635-062-664,10.1002/jbm.a.10149;;14613252;;10.1098/rsif.2008.0071;;18477539;;pmc2475552;;10.1177/0883911506074025;;pmc4238238;;24959845;;10.1089/neu.2014.3439;;pmc6318667;;30920503;;10.3390/gels3010006,"Sannino et al. “Biomedical application of superabsorbent hydrogel for body water elimination in the treatment of edemas”, Wiley Periodicals, Inc., 2003.;;Zhong et al. “Biomaterial for the central nervous system”, J.R.Soc. Interface (2008), 5, 957-975 (Year: 2008).;;Zhang et al. “Three dimensional gelatin and gelatin/hyaluronan hydrogel structure for traumatic brain injury”, Journal of Bioactive and Compatible Polymers, vol. 22, Jan. 2007 (Year: 2007).;;McBride, D.W. et al. 2014 “Reduction of Cerebral Edema after Traumatic Brain Injury Using an Osmotic Transport Device” Journal of Neurotrauma 31:1948-1954.;;Chai, Q. et al. 2017 “Hydrogels for Biomedical Applications: Their Characteristics and the Mechanisms behind Them” Gels 3(6): in 15 pages.",ACTIVE
4,US,A1,US 2013/0115267 A1,160-178-579-269-13X,2013-05-09,2013,US 201213666773 A,2012-11-01,US 201213666773 A;;US 201161555351 P,2011-11-03,COMPOSITIONS AND METHODS FOR REDUCING EDEMA,"The invention provides compositions and methods for the treatment and/or reversal of an edema, e.g., including a central nervous system (CNS) edema, e.g., a brain or a spinal edema, edema in a burned or an injured tissue such as skin, or any tissue edema. In alternative embodiments, the invention provides compositions and methods for a direct treatment and reversal of an edema, e.g., CNS, brain or spinal edema, including a membrane transport device, in vitro and in vivo characterization of edema, and the sensitive early optical detection of the edema, e.g., tissue, CNS or cerebral edema.",ROGERS VICTOR G J;;BINDER DEVIN;;MCBRIDE DEVIN;;HSU MICHAEL;;PARK B HYLE;;UNIV CALIFORNIA,ROGERS VICTOR G J;;BINDER DEVIN;;MCBRIDE DEVIN;;HSU MICHAEL;;PARK B HYLE,,https://lens.org/160-178-579-269-13X,Patent Application,yes,5,1,3,3,0,A61K38/38;;A61K38/40;;A61B5/4878;;A61B5/6868;;A61B5/0066;;A61P43/00;;A61B5/0066;;A61B5/4878;;A61B5/6868;;A61K38/38;;A61K38/40;;A61L29/043;;A61L29/044;;A61L29/16;;A61M27/002;;A61M2027/004,A61M25/00;;A61K38/38;;A61M25/14;;A61P43/00,424/443;;424/400;;514/1.1,0,0,,,,DISCONTINUED
5,US,A1,US 2015/0141950 A1,036-571-599-264-227,2015-05-21,2015,US 201414539385 A,2014-11-12,US 201414539385 A;;US 201213666773 A;;US 201161555351 P,2011-11-03,COMPOSITIONS AND METHODS FOR REDUCING EDEMA,"The invention provides compositions and methods for the treatment and/or reversal of an edema, e.g., including a central nervous system (CNS) edema, e.g., a brain or a spinal edema, edema in a burned or an injured tissue such as skin, or any tissue edema. In alternative embodiments, the invention provides compositions and methods for a direct treatment and reversal of an edema, e.g., CNS, brain or spinal edema, including a membrane transport device, in vitro and in vivo characterization of edema, and the sensitive early optical detection of the edema, e.g., tissue, CNS or cerebral edema.",UNIV CALIFORNIA,RODGERS VICTOR G J;;BINDER DEVIN;;MCBRIDE DEVIN;;HSU MICHAEL;;PARK B HYLE,THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (2017-04-03),https://lens.org/036-571-599-264-227,Patent Application,yes,2,1,3,3,0,A61K38/38;;A61K38/40;;A61B5/4878;;A61B5/6868;;A61B5/0066;;A61P43/00;;A61B5/0066;;A61B5/4878;;A61B5/6868;;A61K38/38;;A61K38/40;;A61L29/043;;A61L29/044;;A61L29/16;;A61M27/002;;A61M2027/004,A61M27/00;;A61L29/04;;A61L29/16,604/500;;604/276,1,1,015-021-478-550-640,10.1002/jbm.a.10149;;14613252,"Sannino et al. âBiomedical application of superabsorbent hydrogel for body water elimination in the treatment of edemasâ, Wiley Periodicals, Inc., 2003.",ACTIVE
6,US,A1,US 2021/0322737 A1,118-483-622-416-990,2021-10-21,2021,US 202117229587 A,2021-04-13,US 202117229587 A;;US 202063009949 P,2020-04-14,COMPOSITIONS AND METHODS FOR REDUCING TRAUMATIC EDEMA FROM SEVERE SPINAL CORD INJURY,"A continuous-flow system for the treatment of edema in an injured central nervous system (CNS) tissue, including: a reversibly implantable device having: an inflow pathway, an outflow pathway, and a fluid flow pathway connecting the first outlet of the inflow pathway and the second inlet of the outflow pathway, wherein the fluid flow pathway includes a semi-permeable membrane; a first reservoir; a fluid-driving apparatus; a second reservoir; and a plurality of fluid flow conduits that fluidically connect the first reservoir, the fluid-driving apparatus, the second reservoir, and the reversibly implantable device; wherein the reversibly implantable device is configured to allow direct contact between the semi-permeable membrane and at least a portion of the injured CNS tissue; wherein the system is configured to contain a solution that pass through the fluid flow pathway and induces osmotic flow of water from the injured CNS tissue across the semipermeable membrane and into the solution, thereby decreasing swelling of the tissue. Also disclosed are related methods for removing water from a traumatically injured central nervous system (CNS) tissue in a subject.",UNIV CALIFORNIA,RODGERS VICTOR G J;;BINDER DEVIN K;;HALE CHRISTOPHER;;YONAN JENNIFER,,https://lens.org/118-483-622-416-990,Patent Application,yes,10,0,1,1,0,A61M27/006;;A61K9/0024;;A61M27/006;;A61M27/008;;A61M2205/3303;;A61M2205/3368;;A61M2205/3327;;A61M2210/1003;;A61M27/002;;A61B2010/0077;;A61B5/032;;A61M2202/0464;;A61B5/031,A61M27/00,,0,0,,,,PENDING
